AstraZeneca PLC - Current Deferred Revenue
AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.The Serie's long term average value is 0.206 Billion United States Dollars. It's latest available value, on 06/30/2024, is -0.447 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2020, to it's latest available value, on 06/30/2024, is +11.68 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2010, to it's latest available value, on 06/30/2024, is -7.14 Billion.
Current Deferred Revenue for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Current Deferred Revenue | 905,699,262,464.00 |
 | Johnson & Johnson - Current Deferred Revenue | 486,508,953,600.00 |
 | AbbVie Inc - Current Deferred Revenue | 399,570,305,024.00 |
 | Roche Holding AG - Current Deferred Revenue | 317,433,206,677.55 |
 | Novartis AG - Current Deferred Revenue | 255,096,620,580.91 |